The Difference
Is Our People

Richard de Bodo

Richard de Bodo Photo

Richard de Bodo

Partner

Contact

Richard de Bodo
310-601-1116

Education

  • Harvard Law School
    Cambridge, Massachusetts
    Juris Doctorate
  • Harvard College
    Cambridge, Massachusetts
    B.A.

Bar Admissions

California

District of Columbia

Honors and Awards

Outstanding Lawyer in Intellectual Property: Patent, Chambers USA (California)
2009-2018

Outstanding Lawyer in Life Sciences: IP/Patent Litigation, Chambers USA (California)
2009-2018

Outstanding Lawyer in Patent Litigation, Best Lawyers
2015-2018

Outstanding Lawyer in Intellectual Property and Life Sciences, Benchmark Litigation (California)
2015-2018

Outstanding Lawyer in Healthcare – Life Sciences, The Legal 500 US
2015-2018

Outstanding Intellectual Property Lawyer, Daily Journal
20010-2018

IP Patent Star, Managing Intellectual Property (California)
2012-2018

Life Sciences Star: Intellectual Property, LMG Life Sciences
2012-2018

Outstanding Intellectual Property Litigation Attorney, Super Lawyers
2005-2020

Outstanding Life Sciences Attorney, Who’s Who Legal
2015-2018

Award recipient: General Patent Litigator of the Year – California, Euromoney/LMG Life Sciences
2016

Award recipient: Best Firm for Biologic Drug Litigations – California, Global Health and Pharma
2016-2017

Award Finalist: Outstanding IP Litigator Award, Managing Intellectual Property
2016

Award Finalist: General Patent Litigator of the Year – California, Euromoney/LMG Life Sciences
2017

Native American Rights Fund, Recognized and honored for pro bono work
2016

Fellow, Litigation Counsel of America

Former Co-Chair, American Bar Association Annual Intellectual Property Litigation Committee

Former Co-Chair, American Bar Assosicatio Annual Intellectual Property Law Conference

Instructor on Trial Advocacy and Trial Strategy, National Institute of Trial Advocacy

Instructor on Trial Advocacy and Trial Strategy, Hastings College of Advocacy

Judicial Clerk, US Court of Appeals and US District Court

 

Attorney Bio

Richard de Bodo is a partner in the technology/intellectual property group.  He is lead trial counsel in high-stakes, cutting-edge patent, trade secret, trademark, and copyright cases for the world’s leading technology, electronics, software, pharmaceuticals, biotechnology, biosimilars, and medical device companies. Rich has won significant victories for clients in federal and state courts throughout the US, appellate courts, the International Trade Commission (ITC), US Patent Office proceedings, arbitrations, and other forums on behalf of companies and individuals seeking to protect or enforce their IP, defending US and international markets for their products, and/or launching new products, entering new markets, and seeking to overcome barriers to entry.

Rich has significant experience litigating patent infringement and inventorship cases in the district courts and the ITC, post-grant challenges to patents before the PTAB, and counseling companies and individuals on how to obtain IP or broaden IP protections and strategy. He is consistently rated one of the best IP lawyers in the US. According to Chambers USA, “Clients are impressed by Rich’s brilliant mind and unmatched strategic skills.” Chambers quoted one client, “When the stakes are high, Rich is the only person I’d go to. He gets the job done in a measured and calm manner.” Another client stated: “Rich is the person you need when you’re faced with highly complicated IP legal matters that involve many variables.”

Prior to joining MWM, Rich served as chair of the IP and patent litigation practice at several major global law firms.

Representative Experience

Technolgy and Software Companies

  • Won summary judgment of noninfringement and Federal Circuit appeal in high-stakes patent infringement case involving launch of major new Internet search technology;
  • Won summary judgment in district court, summary determination at the ITC, and Federal Circuit appeal in bet-the-company case that resulted in a landmark Federal Circuit ruling on the Digital Millennium Copyright Act;
  • Won summary judgment of noninfringement in two patent infringement cases involving company’s market-leading photographic-quality printers and inks;
  • Won summary judgment of noninfringement in high-stakes patent infringement case involving digital cameras and camcorders;
  • Successfully represented leading decontamination and disinfection company in cutting-edge patent and trademark litigation, validated company’s patented technology, and secured and strengthened its market-leading brand;
  • Successfully represented leading semiconductor company in high-stakes trade secrets and employee solicitation case involving semiconductors that perform RF turning and transceiving and defeated preliminary injunction motion brought by a leading competitor;
  • Won trial and obtained a $120 million jury verdict and worldwide injunction in a patent and trade secrets case involving complex computer software;

Pharmaceutical, Biotechnology, and Life Sciences Companies

  • Won trial for pharmaceutical company in high-stakes Hatch-Waxman patent litigation involving client’s best-selling anesthetic drug and obtained a permanent injunction blocking market entry by competitor on all three asserted patents;
  • Successfully obtained freedom to operate for biopharmaceutical company in high-stakes inventorship litigation over 37 US and international patents concerning peptide therapies that stimulate red blood cell formation;
  • Won trial court and Federal Circuit victories and obtained a permanent injunction for leading pharmaceutical company in Hatch-Waxman patent case involving billion-dollar anti-ulcer, heartburn, and acid reflux drug;
  • Successfully assisted biosimilar manufacturer in invalidating key blocking patents, overcoming multiple barriers to entry, navigating the BPCIA, and launching major biosimilar antibody product several years ahead of schedule;
  • Won multiple summary judgments of noninfringement for leading pharmaceutical company in patent lawsuit targeted at its billion-dollar cancer drug and its international cancer research program;
  • Successfully represented biopharmaceutical company in asserting its crown-jewel patents relating to humanized antibodies and obtained lucrative licenses from market-leading pharm company for four blockbuster biologic drugs;
  • Successfully represented leading pharmaceutical company in high-stakes patent infringement case involving drug for severe sepsis and challenges to the company’s conduct in clinical trials and the FDA approval process;
  • Successfully represented leading pharmaceutical company in patent and antitrust lawsuit and defeated challenges to company’s crown-jewel patents covering its blockbuster AIDS therapies;
  • Successfully represented leading biotechnology company in multiple bet-the-company patent cases defending and asserting its market-leading technologies involving DNA microarrays and DNA sequencing;
  • Won district court and Federal Circuit victories for a vaccine company in a patent case that resulted in a significant Federal Circuit decision on inventorship and university ownership of patents;
  • Successfully represented biotechnology company in high-stakes patent case and preserved freedom to operate for its market-leading diagnostic test and immunoassay technology;

Native American Law

  • Won federal district court trial in lawsuit under the Voting Rights Act and US Consitution on behalf of Alaska Native voters and negotiated settlement establishing that for the first time, the State of Alaska would provide voters its Offical Election Pamphlet and other voting materials in multiple different Alaska Native languages and dialects;
  • Won federal district court injunction under the US Constitution and Voting Rights Act prohibiting North Dakota from enforcing restrictive voter identification requirements in presidential election;
  • Successfully represented the Native American Rights Fund (NARF) and obtained substantial attorneys’ fees award based on NARF’s work for 14 years in landmark litigation relating to federal mismanagement of Native American trust assets.

Professional Associations & Memberships

State Bar of California